Patent expiration risks for total worldwide prescription drug revenue 2023-2028

Published by
Matej Mikulic,
Oct 6, 2023
This statistic depicts the total prescription drug revenue worldwide that is at risk due to patent expiration from 2023 to 2028. In 2023, the industry is expected to have 51 billion U.S. dollars in prescription drug sales worldwide at risk due to patent expiration. After the expiration of patent protection, other companies are allowed to make cheaper generics of the originally branded drug.

Worldwide total prescription drug revenue at risk from patent expiration from 2023 to 2028 (in billion U.S. dollars)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2023

Region

Worldwide

Survey time period

as of August 2023

Supplementary notes

‘Total Sales at Risk’ represents the worldwide product sales in the year prior to patent expiry but allocated to the year of expiry.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Generics and biosimilars "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizerNovartis
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu